Stephan, Clifford Certification Officer and Associate Professor

The Stephan Lab is focused on drug discovery research. Dr. Stephan directs both the Combinatorial Drug Discovery Program (CDDP) core and the Microphysiological Lead Optimization and Toxicity Screening (MLOTS) facilities. The CDDP is a high throughput screening and automated microscopy core focused on discovering new therapeutics from library screening and drug repurposing alone or in multi-drug combinations. MLOTS is a low to medium throughput core focused on lead optimization for new chemical entities with the capability of testing compounds in complex in vitro models (e.g., spheroids, organoids) and de-risking drug leads by evaluating their potential cardiovascular or CNS toxicities via micro electrode array or hepatotoxcity in a microfluidic liver model.